Emerald Mutual Fund Advisers Trust Abbott Laboratories Transaction History

Emerald Mutual Fund Advisers Trust

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$109.52 - $120.96 $45,450 - $50,198	-415 Reduced 19.28%	1,738 $197,000
Q4 2023 Feb 05, 2024	BUY	$90.19 - $110.4 $61,239 - $74,961	679 Added 46.07%	2,153 $236,000
Q3 2023 Oct 26, 2023	SELL	$95.53 - $114.62 $3,152 - $3,782	-33 Reduced 2.19%	1,474 $142,000
Q2 2023 Aug 10, 2023	BUY	$100.78 - $112.29 $151,875 - $169,221	1,507 New	1,507 $164,000
Q4 2022 Feb 03, 2023	SELL	$95.06 - $111.52 $38,309 - $44,942	-403 Reduced 17.39%	1,915 $210,000
Q3 2022 Oct 25, 2022	BUY	$96.76 - $112.03 $43,348 - $50,189	448 Added 23.96%	2,318 $224,000
Q2 2022 Jul 29, 2022	BUY	$102.07 - $123.37 $99,926 - $120,779	979 Added 109.88%	1,870 $203,000
Q1 2022 Apr 29, 2022	BUY	$114.02 - $139.04 $101,591 - $123,884	891 New	891 $105,000
Q1 2020 Apr 30, 2020	SELL	$62.82 - $91.86 $70,107 - $102,515	-1,116 Closed	0 $0
Q4 2019 Jan 29, 2020	BUY	$78.51 - $87.4 $87,617 - $97,538	1,116 New	1,116 $97,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.